कोशिश गोल्ड - मुक्त
'Industry needs to come out with proposals to utilise scheme funds'
Chronicle Pharmabiz
|September 18, 2025
WHILE the Central government has various kinds of schemes to support the medical devices industry, the industry may have to come out with good proposals so that the funds can be fully utilised, says Ravindra Pratap Singh, joint secretary, Department of Pharmaceuticals (DoP).
Addressing the session titled 'Strengthening India's Medical Device Parks: Roadmap for Global-Standard Manufacturing' as the Chair on the 2nd Day of 'India MedTech Expo 2025', Singh said, "We have various kinds of schemes to support the manufacturing of key components, necessary raw material, skill development, support for clinical studies, development of common infrastructure, and industry promotion. But we are not able to fully exhaust the fund available. The industry needs to come forward with good proposals when the next round of applications are invited."
यह कहानी Chronicle Pharmabiz के September 18, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Chronicle Pharmabiz से और कहानियाँ
Chronicle Pharmabiz
Recent developments in Bangladesh pharma industry
Over the past four decades, the pharmaceutical industry in Bangladesh has undergone a sweeping transformation- emerging from its modest, import-dependent roots into a powerful, innovation-driven sector at the forefront of national development. What once relied heavily on foreign suppliers for basic medicines has now evolved into a self-reliant, technologically advanced industry capable of producing everything from lifesaving generics to complex oncology drugs.
7 mins
October 30, 2025
Chronicle Pharmabiz
Asia Labex showcases latest advancements in lab technology
DRIVEN by increased investment in pharmaceutical and biotech R&D, a rising need for advanced diagnostic equipment due to disease prevalence, and the growing adoption of automation in labs, the pharma laboratory equipment market has positive prospects.
6 mins
October 30, 2025
Chronicle Pharmabiz
AMMOI demands insurance for Ayurveda day care therapies
THE Ayurvedic Medicine Manufacturers Organ- isation of India (AM- MOI) has sought Union Ayush Minister Prataprao Jadhav's immediate interven- tion to ensure health insurance covers for Ayurvedic day care therapies.
2 mins
October 30, 2025
Chronicle Pharmabiz
Global API market poised for significant changes
The global API market is poised for significant transformation in the coming decade, with growth concentrated in complex APIs, biologics, peptides, and high-potency APIS (HPAPIs).
6 mins
October 30, 2025
Chronicle Pharmabiz
PvPI identifies 16 India specific signals
THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been communicated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.
2 mins
October 30, 2025
Chronicle Pharmabiz
CDSCO sets up digital system to monitor quality of solvents
THE Central Drugs Standard Control Organisation (CDSCO) has set up a Digital Monitoring System on the Online National Drugs Licensing System (ONDLS) portal to monitor the supply chain as well as quality of the high-risk solvents and has asked the State drug controllers to direct all manufacturers of pharma grade solvents to obtain manufacturing license through the portal.
2 mins
October 30, 2025
Chronicle Pharmabiz
Surgicals import grows 11.58%, exports remain stagnant in August
IMPORTS of surgical equipment to the country have reported a decline of 11.58% even as the export of these products was almost stagnant during the month of August, 2025. For the first five months of the current fiscal, imports registered almost 9% growth compared to the same period a year ago.
2 mins
October 30, 2025
Chronicle Pharmabiz
API China focuses on innovation & global co-operation
In recent years, the scale of China's pharmaceutical active pharmaceutical ingredients (APIs) and its global market share have gradually increased. The China API market is experiencing significant growth, driven by expanding global pharmaceutical demand, an aging population, rising chronic disease rates, and the expiration of patents boosting demand for generics.
6 mins
October 30, 2025
Chronicle Pharmabiz
PVPI identifies 16 India specific signals
THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been com- municated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.
2 mins
October 30, 2025
Chronicle Pharmabiz
PM&AC 2025 redefines excellence in pharma manufacturing
THE 7th Annual Pharma Manufacturing & Automation Convention (PM&AC) 2025, co-located with the Pharma Manufacturing & Automation Excellence Awards, concluded on October 8 and 9 at Novotel HICC, Hyderabad, with resounding success.
3 mins
October 30, 2025
Listen
Translate
Change font size